Literature DB >> 16105653

Molecular genetics of tyrosine 3-monooxygenase and inherited diseases.

Kazuto Kobayashi1, Toshiharu Nagatsu.   

Abstract

Tyrosine 3-monooxygenase (tyrosine hydroxylase, TH) catalyzes the initial and rate-limiting step in the catecholamine biosynthesis. Alteration in TH activity is involved in the pathogenesis of certain disorders derived from catecholaminergic dysfunction. In the present review, we focus on recent advances in molecular genetic study of TH function and inherited diseases. Knockout mice lacking TH gene show severe catecholamine depletion and perinatal lethality. Mice heterozygous for the TH mutation exhibit defects in some neuropsychological functions. Dopamine-deficient mice impair motor control and operant learning during postnatal development. In addition, some point mutations in the human TH gene underlie the inherited diseases, including the recessive form of L-DOPA-responsive dystonia, parkinsonism in infancy, or progressive encephalopathy. These mutations indeed appear to reduce TH activity or influence expression of TH protein. Advances in molecular genetic studies provide a deeper understanding of the relationship between the alteration in TH activity and the pathology of catecholaminergic systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105653     DOI: 10.1016/j.bbrc.2005.07.186

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  A possible pathophysiological role of tyrosine hydroxylase in Parkinson's disease suggested by postmortem brain biochemistry: a contribution for the special 70th birthday symposium in honor of Prof. Peter Riederer.

Authors:  Akira Nakashima; Akira Ota; Yoko S Kaneko; Keiji Mori; Hiroshi Nagasaki; Toshiharu Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2012-05-27       Impact factor: 3.575

Review 2.  Complex molecular regulation of tyrosine hydroxylase.

Authors:  Izel Tekin; Robert Roskoski; Nurgul Carkaci-Salli; Kent E Vrana
Journal:  J Neural Transm (Vienna)       Date:  2014-05-28       Impact factor: 3.575

Review 3.  Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines.

Authors:  Toshi Nagatsu; Makoto Sawada
Journal:  Cell Mol Neurobiol       Date:  2006-07-06       Impact factor: 5.046

4.  Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome.

Authors:  Ronald McGregor; Ming-Fung Wu; Brent Holmes; Hoa Anh Lam; Nigel T Maidment; Joseph Gera; Akihiro Yamanaka; Jerome M Siegel
Journal:  J Neurosci       Date:  2021-12-01       Impact factor: 6.709

5.  Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk.

Authors:  Lian Zhang; Fangwen Rao; Kuixing Zhang; Srikrishna Khandrika; Madhusudan Das; Sucheta M Vaingankar; Xuping Bao; Brinda K Rana; Douglas W Smith; Jennifer Wessel; Rany M Salem; Juan L Rodriguez-Flores; Sushil K Mahata; Nicholas J Schork; Michael G Ziegler; Daniel T O'Connor
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 6.  Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.

Authors:  Toshiharu Nagatsu; Ikuko Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2016-08-04       Impact factor: 3.575

Review 7.  Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines.

Authors:  A Nakashima; N Hayashi; Y S Kaneko; K Mori; E L Sabban; Toshiharu Nagatsu; A Ota
Journal:  J Neural Transm (Vienna)       Date:  2009-04-25       Impact factor: 3.575

8.  Adrenergic polymorphism and the human stress response.

Authors:  Fangwen Rao; Lian Zhang; Jennifer Wessel; Kuixing Zhang; Gen Wen; Brian P Kennedy; Brinda K Rana; Madhusudan Das; Juan L Rodriguez-Flores; Douglas W Smith; Peter E Cadman; Rany M Salem; Sushil K Mahata; Nicholas J Schork; Laurent Taupenot; Michael G Ziegler; Daniel T O'Connor
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 9.  Human tyrosine hydroxylase in Parkinson's disease and in related disorders.

Authors:  Toshiharu Nagatsu; Akira Nakashima; Hiroshi Ichinose; Kazuto Kobayashi
Journal:  J Neural Transm (Vienna)       Date:  2018-07-11       Impact factor: 3.575

10.  No Evidence for Association between Tyrosine Hydroxylase Gene Val81Met Polymorphism and Susceptibility to Tardive Dyskinesia in Schizophrenia.

Authors:  Heon-Jeong Lee; Seung-Gul Kang; Jung-Eun Choi; Young-Min Park; Se-Won Lim; Min Kyu Rhee; Seung-Hyun Kim; Leen Kim
Journal:  Psychiatry Investig       Date:  2009-06-30       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.